Community Healthcare Trust (CHCT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Feb, 2026Executive summary
Operates a diversified healthcare real estate portfolio with 201 properties across 36 states, 90.9% leased, and a 6.7-year average lease term as of March 31, 2025.
Q1 2025 net income was $1.6M, down from $3.7M in Q1 2024, due to higher interest and operating expenses.
FFO and AFFO per diluted share were $0.47 and $0.55, respectively, both down year-over-year.
Acquired a behavioral residential treatment facility for $9.7M and disposed of a building in Ohio for $0.6M.
Seven properties under definitive purchase agreements for $169.5M, with anticipated returns of 9.1%–9.75%.
Financial highlights
Total revenue for Q1 2025 was $30.1M, up 2.5% year-over-year and 2.7% sequentially.
Property operating expenses rose to $6.1M, mainly due to seasonal utility and snowplow costs.
G&A expenses increased to $5.1M, driven by non-cash amortization and seasonal compensation.
Interest expense increased to $6.4M, reflecting higher average balances and rates.
Comprehensive loss for Q1 2025 was $(3.6)M, mainly due to a $3.4M decrease in fair value of cash flow hedges.
Outlook and guidance
Seven properties under contract for $169.5M expected to close through 2027, with additional pipeline including a $4.1M property and a $60M development term sheet.
$28.2M in tenant improvement commitments and $3.3M in capital improvement commitments as of March 31, 2025.
Quarterly dividend raised to $0.47/share, annualized at $1.88/share.
Will fund acquisitions through asset sales, revolver draws, and operations, avoiding significant leverage increases.
Latest events from Community Healthcare Trust
- Proxy covers director elections, pay alignment, auditor ratification, and ESG priorities.CHCT
Proxy Filing12 Mar 2026 - Key votes include director elections, executive pay, and auditor ratification for 2026.CHCT
Proxy Filing12 Mar 2026 - Q4 2025 saw 5.6% revenue growth, $14.4M net income, and a raised dividend.CHCT
Q4 202518 Feb 2026 - Net loss and lower FFO/AFFO in Q2 2024 due to tenant credit issues, but acquisitions and dividend growth continued.CHCT
Q2 20242 Feb 2026 - Revenue up 3.1%, net income down 49.9%, $400M revolver expanded, and dividend growth continues.CHCT
Q3 202417 Jan 2026 - AFFO and FFO per share declined, but acquisitions and credit facility expansion support growth.CHCT
Q4 202423 Dec 2025 - Healthcare REIT launches $500M shelf, including $300M ATM equity, to fund growth and repay debt.CHCT
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, pay, and auditor; board is independent and compensation is performance-based.CHCT
Proxy Filing1 Dec 2025 - Key votes on directors, executive pay, and auditor set for May 2025 annual meeting.CHCT
Proxy Filing1 Dec 2025